NCT01013012

Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 94 (actual)
• Sponsor: Yonsei University · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to study the efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery.

Conditions

• Nausea
• Vomiting

Interventions

Type	Name	Description
DRUG	ramosetron with saline	Group A : saline 1 ml, ramosetron 6μg/kg
DRUG	ramosetron with dexamethasone	Group B : dexamethasone 4 mg, ramosetron 6μg/kg

Timeline

• Start date: 2008-01-01
• Primary completion: 2008-11-01
• Completion: 2008-11-01
• First posted: 2009-11-13
• Last updated: 2012-02-03